Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to KnowZacks Investment Research • 9h
European Commission Approves Pfizer's DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia BBusiness Wire • Thursday
Seeking Clues to Pfizer (PFE) Q2 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • Thursday
This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for PfizerThe Motley Fool • Wednesday
Pfizer's gene therapy for rare genetic bleeding disorder succeeds in late-stage trialCNBC • Wednesday
Pfizer's hemophilia A gene therapy found superior to current treatment in late-stage trialReuters • Wednesday
Pfizer announces positive results from late-stage trial of Hemophilia A treatmentMarket Watch • Wednesday
Pfizer Announces Positive Topline Results From Phase 3 Study of Hemophilia A Gene Therapy CandidateBusiness Wire • Wednesday
Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026Benzinga • 07/18/24
Is Pfizer Stock A Buy After Breaking Out On Obesity Treatment Fervor?Investors Business Daily • 07/18/24